EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION AND MAINTENANCE THERAPY FOR CROHN’S DISEASE: RESULTS FROM THE PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED DIVERSITY1 STUDY

Severine Vermeire  1     David T. Rubin  2     Mamoru Watanabe  3     Stefan Schreiber  4     Rajiv Mehta  5     Xavier Roblin  6     Mark C. Genovese  7     Tomasz Masior  8     Rahul Barron  8     Franck-Olivier Le Brun  8     Silvio Danese  9, 10    
1 UZ Leuven, Leuven, Belgium
2 Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, United States
3 Tokyo Medical and Dental University, Tokyo, Japan
4 University Hospital Schleswig-Holstein, Kiel, Germany
5 Surat Institute of Digestive Sciences Hospital, Surat, India
6 University Hospital of Saint-Étienne, Saint-Étienne, France
7 Gilead Sciences Inc., Foster City, United States
8 Galapagos GmbH, Basel, Switzerland
9 IRCCS Hospital San Raffaele, Milan, Italy
10 Vita-Salute San Raffaele University, Milan, Italy

Topic
Endoscopy, IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing